308 related articles for article (PubMed ID: 25051025)
41. Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance.
Patel P; Bryan RT; Wallace DM
ScientificWorldJournal; 2011; 11():2550-8. PubMed ID: 22235185
[TBL] [Abstract][Full Text] [Related]
42. [Enhanced endoscopic imaging for urothelial cancer].
Knoll T; Bach T
Aktuelle Urol; 2019 Feb; 50(1):76-83. PubMed ID: 30261550
[TBL] [Abstract][Full Text] [Related]
43. Advancements in optical techniques and imaging in the diagnosis and management of bladder cancer.
Rose TL; Lotan Y
Urol Oncol; 2018 Mar; 36(3):97-102. PubMed ID: 29288006
[TBL] [Abstract][Full Text] [Related]
44. Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors.
Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Roessler W
J Urol; 2002 Jul; 168(1):67-71. PubMed ID: 12050494
[TBL] [Abstract][Full Text] [Related]
45. [Diagnostics of nonmuscle-invasive urothelial cell carcinoma of the bladder].
Tschirdewahn S; Vom Dorp F
Urologe A; 2015 Apr; 54(4):480-3. PubMed ID: 25784270
[TBL] [Abstract][Full Text] [Related]
46. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
[TBL] [Abstract][Full Text] [Related]
47. Visualization of the basement membrane zone of the bladder by optical coherence tomography: feasibility of noninvasive evaluation of tumor invasion.
Hermes B; Spöler F; Naami A; Bornemann J; Först M; Grosse J; Jakse G; Knüchel R
Urology; 2008 Sep; 72(3):677-81. PubMed ID: 18455778
[TBL] [Abstract][Full Text] [Related]
48. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
[TBL] [Abstract][Full Text] [Related]
49. The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation.
Garfield SS; Gavaghan MB; Armstrong SO; Jones JS
Can J Urol; 2013 Apr; 20(2):6682-9. PubMed ID: 23587507
[TBL] [Abstract][Full Text] [Related]
50. Fluorescence cystoscopy with high-resolution optical coherence tomography imaging as an adjunct reduces false-positive findings in the diagnosis of urothelial carcinoma of the bladder.
Schmidbauer J; Remzi M; Klatte T; Waldert M; Mauermann J; Susani M; Marberger M
Eur Urol; 2009 Dec; 56(6):914-9. PubMed ID: 19674831
[TBL] [Abstract][Full Text] [Related]
51. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
[TBL] [Abstract][Full Text] [Related]
52. Fluorescence guided optical coherence tomography for the diagnosis of early bladder cancer in a rat model.
Wang ZG; Durand DB; Schoenberg M; Pan YT
J Urol; 2005 Dec; 174(6):2376-81. PubMed ID: 16280851
[TBL] [Abstract][Full Text] [Related]
53. The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer.
Witjes JA; Douglass J
Nat Clin Pract Urol; 2007 Oct; 4(10):542-9. PubMed ID: 17921969
[TBL] [Abstract][Full Text] [Related]
54. Confocal laser endomicroscopy of bladder and upper tract urothelial carcinoma: a new era of optical diagnosis?
Chen SP; Liao JC
Curr Urol Rep; 2014 Sep; 15(9):437. PubMed ID: 25002073
[TBL] [Abstract][Full Text] [Related]
55. Toward Automated
Lucas M; Liem EIML; Savci-Heijink CD; Freund JE; Marquering HA; van Leeuwen TG; de Bruin DM
J Endourol; 2019 Nov; 33(11):930-937. PubMed ID: 31657629
[No Abstract] [Full Text] [Related]
56. Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.
Drăgoescu O; Tomescu P; Pănuş A; Enache M; Maria C; Stoica L; Pleşea IE
Rom J Morphol Embryol; 2011; 52(1):123-7. PubMed ID: 21424043
[TBL] [Abstract][Full Text] [Related]
57. A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications.
Cauberg EC; de Bruin DM; Faber DJ; van Leeuwen TG; de la Rosette JJ; de Reijke TM
Eur Urol; 2009 Aug; 56(2):287-96. PubMed ID: 19285787
[TBL] [Abstract][Full Text] [Related]
58. Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer.
Cauberg EC; Kloen S; Visser M; de la Rosette JJ; Babjuk M; Soukup V; Pesl M; Duskova J; de Reijke TM
Urology; 2010 Sep; 76(3):658-63. PubMed ID: 20223505
[TBL] [Abstract][Full Text] [Related]
59. Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.
Sung HH; Scherr DS; Slaton J; Liu H; Feeny KL; Lingley-Papadopoulos C; Gearheart J; Zara JM; Lerner SP
Urol Oncol; 2021 Jul; 39(7):434.e23-434.e29. PubMed ID: 33934964
[TBL] [Abstract][Full Text] [Related]
60. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
